fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

A person’s diet, acidity of urine may affect susceptibility to UTIs

Written by | 23 Jul 2015

The acidity of urine — as well as the presence of small molecules related to diet — may influence how well bacteria can grow in the urinary tract,… read more.

High blood pressure linked to reduced Alzheimer’s risk, meds may be reason

Written by | 14 Jul 2015

A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.

High blood pressure linked to reduced Alzheimer's risk, meds may be reason

Written by | 14 Jul 2015

A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.

Mortality in coronary artery bypass graft surgery lowered by preoperative statin treatment

Written by | 8 Jul 2015

by Bruce Sylvester: A study of the protective effect of heart medications that patients receive before coronary artery bypass graft (CABG) surgery suggests that statins reduce the risk… read more.

World Heath Matters: Denmark: Weight loss without bone loss?

Written by | 30 Jun 2015

by Gary Finnegan: Rapid weight loss can lead to a loss of bone mass and an increased risk of bone fractures. A study by University of Copenhagen, Hvidovre… read more.

ASCO 2015 Report: Dual immunotherapy improves progression-free survival in advanced melanoma

Written by | 10 Jun 2015

by Bruce Sylvester: Treatment of advanced melanoma with a combination of  nivolumab (Opdivo™) and ipilimumab (Yervoy™) or with nivolumab alone increases progression-free survival over ipilimumab monotherapy, researchers reported… read more.

ASCO 2015 Report: Pembrolizumab shows “remarkable” efficacy in head and neck cancer

Written by | 8 Jun 2015

by Bruce Sylvester: Pembrolizumab (Keytruda®), an anti-PD-1 antibody immunotherapy has shown efficacy in one fourth of patients with recurrent or metastatic head and neck cancer, researchers reported on… read more.

ASCO Report 2015: Immunotherapy nivolumab improves survival in squamous-non-small cell lung cancer

Written by | 4 Jun 2015

by Bruce Sylvester: In a Phase III trial comparing standard docetaxel chemotherapy with immunotherapy nivolumab, researchers reported that subjects with squamous-non-small cell lung cancer treated with nivolumab lived… read more.

Video Interview and editorial from the BSH 2015: Professor Graham Jackson discusses the journey from despair to hope in multiple myeloma. Click on the image for interview and editorial.

Written by | 1 Jun 2015

Graham Jackson, Professor of Clinical haematology, Newcastle upon Tyne and former president of the British Society for Haematology (BSH). Article by Christine Clark: In the 1970s the prospect… read more.

Strong statin-diabetes link appears in study

Written by | 28 May 2015

by Bruce Sylvester: A retrospective study of US military health system (Tricare) beneficiary medical records suggests that subjects using statin drugs to control cholesterol are at an increased… read more.

Diabetes drug may reduce heart attack risk in HIV patients

Written by | 21 May 2015

In patients with HIV, a diabetes drug may have benefits beyond lowering blood sugar. A new study from researchers at Washington University School of Medicine in St. Louis… read more.

Detect drug use from a single fingerprint

Written by | 20 May 2015

Research published today in the journal Analyst has demonstrated a new, noninvasive test that can detect cocaine use through a simple fingerprint. For the first time, this new fingerprint method… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.